As an active clinician scientist, Dr. Young’s principal research interest includes understanding the molecular basis of mood disorders and their treatment and how to apply these findings to the clinical setting. His research is particularly focused on understanding the processes that lead to long-term changes in brain structure and function in patients with bipolar disorder and how these changes can be targeted by mood stabilizing drugs.

Professor Trevor Young will serve as Acting Vice-President and Provost, for a six-month term, effective July 1, 2021 to December 31, 2021; Professor Cheryl Regehr returns January 1, 2022.